Bcl-x Gene Expression in Hodgkin's Disease

References

• Kerr J. F. R., Wyllie A. H., Currie A. R. Apoptosis: a basic biologic phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 1972; 26: 239–257
   PubMed Web of Science ®Google Scholar
• Wyllie A. H., Kerr J. F. R., Currie A. R. Cell death: the significance of apoptosis. Int. Rev. Cytol. 1980; 68: 251–306
   PubMedGoogle Scholar
• Fairbairn L. J., Cowling G. J., Reipert B. M., Dexter T. M. Suppression of apoptosis allows differentiation and development of a multipotent hematopoietic cell line in the absence of added growth factors. Cell 1993; 74: 823–832
   PubMed Web of Science ®Google Scholar
• Williams G. T., Smith C. A., Spooncer E., Dexter T. M., Taylor T. R. Haematopoietic colony stimulating factors promote cell survival by suppressing apoptosis. Nature 1990; 343: 76–79
   PubMed Web of Science ®Google Scholar
• Cohen J. J., Duke R. C. Glucocorticoid activation of a calcium-dependent endonuclease in thymocyte nuclei leads to cell death. J. Immunol. 1984; 132: 38–42
   PubMed Web of Science ®Google Scholar
• Sellins K. S., Cohen J. J. Gene induction by γ-irradiation leads to DNA fragmentation in lymphocytes. J. Immunol. 1987; 139: 3199–3206
   PubMed Web of Science ®Google Scholar
• Warters R. L. Radiation-induced apoptosis in a murine T-cell hybridoma. Cancer Res. 1992; 52: 883–890
   PubMed Web of Science ®Google Scholar
• Barry M. A., Behnke C. A., Eastman A. Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia. Biochem. Pharmacol. 1990; 40: 2353–2362
   PubMed Web of Science ®Google Scholar
• Evans D. L., Dive C. Effects of cisplatin on the induction of apoptosis in proliferating hepatoma cells and nonproliferating immature thymocytes. Cancer Res. 1993; 53: 2133–2139
   PubMed Web of Science ®Google Scholar
• Gorczyca W., Gong J., Ardelt B., Traganos F., Darzynkiewicz Z. The cell cycle related differences in susceptibility of HL-60 cells to apoptosis induced by various antitumor agents. Cancer Res. 1993; 53: 3186–3192
   PubMed Web of Science ®Google Scholar
• Steller H. Mechanisms and genes of cellular suicide. Science 1995; 267: 1445–1449
   PubMed Web of Science ®Google Scholar
• Cleary M. L., Smith S. D., Sklar J. Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation. Cell 1986; 47: 19–28
   PubMed Web of Science ®Google Scholar
• Tsujimoto Y., Croce C. M. Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc. Natl. Acad. Sci. USA 1986; 83: 5214–5218
   PubMed Web of Science ®Google Scholar
• Reed J. C. Bcl-2 and the regulation of programmed cell death. J. Cell Biol. 1994; 124: 1–6
   PubMed Web of Science ®Google Scholar
• Boise L. H., Gonzalez-Garcia M., Postema C. E., Ding L., Lindsten T., Turka L. A., Mao X., Nunez G., Thompson C. B. Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 1993; 74: 597–608
   PubMed Web of Science ®Google Scholar
• Oltvai Z. N., Milliman C. L., Korsmeyer S. J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993; 74: 609–619
   PubMed Web of Science ®Google Scholar
• Sato T., Hanada M., Bodrug S., Irie S., Iwama N., Boise L. H., Thompson C. B., Golemis E., Fong L., Wang H. G., Reed J. C. Interactions among members of the bcl-2 protein family analyzed with a yeast two-hybrid system. Proc. Natl. Acad. Sci. USA 1994; 91: 9238–9242
   PubMed Web of Science ®Google Scholar
• Sedlak T. W., Oltvai Z. N., Yang E., Wang K., Boise L. H., Thompson C. B., Korsmeyer S. J. Multiple Bcl-2 family members demonstrate selective dimerizations with Bax. Proc. Natl. Acad. Sci. USA 1995; 92: 7834–7838
   PubMed Web of Science ®Google Scholar
• Gougeon M. L., Montagnier L. Apoptosis in AIDS. Science 1993; 260: 1269–1270
   PubMed Web of Science ®Google Scholar
• Raza A., Gezer S., Mundle S., Gao X-Z., Alvi S., Borok R., Rifkin S., Iftikhar A., Shetty V., Parcharidou A., Loew J., Marcus B., Khan Z., Chaney C., Showel J., Gregory S., Preisler H. Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes. Blood 1995; 86: 268–276
   PubMed Web of Science ®Google Scholar
• Thompson C. B. Apoptosis in the pathogenesis and treatment of disease. Science 1995; 267: 1456–1462
   PubMed Web of Science ®Google Scholar
• Pezzella F., Gatter K. What is the value of bcl-2 protein detection for histopathologists?. Histopathology 1995; 26: 89–93
   PubMed Web of Science ®Google Scholar
• Schlaifer D., Brousset P., Attal M., Massip P., Payen C., Marchou B., Huguet F., Muller C., Laurent G., Pris J., Delsol G. Bcl-2 proto-oncogene and Epstein-Barr virus latent membrane protein-1 expression in AIDS-related lymphoma. Histopathology 1994; 25: 77–82
   PubMed Web of Science ®Google Scholar
• Krajewski S., Krajewska M., Shabaik A., Wang H. G., Irie S., Fong L., Reed J. C. Immunohistochemical analysis of in vivo patterns of bcl-x expression. Cancer Res. 1994; 54: 5501–5507
   PubMed Web of Science ®Google Scholar
• Schlaifer D., March M., Krajewski S., Laurent G., Pris J., Delsol G., Reed J. C., Brousset P. High expression of the bcl-x gene in Reed-Sternberg cells of Hodgkin's disease. Blood 1995; 85: 2671–2674
   PubMed Web of Science ®Google Scholar
• Park J. R., Bernstein I. D., Hockenbery D. M. Primitive human hematopoietic precursors express Bcl-x but not Bcl-2. Blood 1995; 86: 868–876
   PubMed Web of Science ®Google Scholar
• Stetler-Stevenson M., Crush-Stanton S., Cossman J. Involvement of the bcl-2 gene in Hodgkin's disease. J. Natl. Cancer Inst. 1990; 82: 855–858
   PubMed Web of Science ®Google Scholar
• Louie D. C., Kant J. A., Brooks J. J., Reed J. C. Absence of t(14;18) major and minor breakpoints and of bcl-2 protein overproduction in Reed-Sternberg cells of Hodgkin's disease. Am. J. Pathol. 1991; 139: 1231–1237
   PubMed Web of Science ®Google Scholar
• Cabanillas F., Pathak S., Trujillo J., Grant G., Cork A., Hagemeister F., Velasquez W., McLaughlin P., Redman J., Katz R., Butler J., Freireich E. Cytogenetic features of Hodgkin's disease suggest possible origin from a lymphocyte. Blood 1988; 71: 1615–1617
   PubMed Web of Science ®Google Scholar
• Corbally N., Grogan L., Keane M. M., Devaney D. M., Dervan P. A., Carney D. N. Bcl-2 rearrangement in Hodgkin's disease and reactive lymph nodes. Am. J. Clin. Pathol. 1994; 101: 756–760
   PubMed Web of Science ®Google Scholar
• Chao D. T., Linette G. P., Boise L. H., White L. S., Thompson C. B., Korsmeyer S. J. Bcl-x-L and Bcl-2 repress a common pathway of cell death. J. Exp. Med. 1995; 182: 821–828
   PubMed Web of Science ®Google Scholar
• Kozopas K. M., Yang T., Buchan H. L., Zhou P., Craig R. W. MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2. Proc. Natl. Acad. Sci. USA 1993; 90: 3516–3520
   PubMed Web of Science ®Google Scholar
• Yang E., Zha J., Jockel J., Boise L. H., Thompson C. B., Korsmeyer S. J. Bad, a heterodimeric partner for bcl-xL and bcl-2, displaces bax and promotes cell death. Cell 1995; 80: 285–291
   PubMed Web of Science ®Google Scholar
• Takayama S., Sato T., Krajewski S., Kochel K., Irie S., Millan J. A., Reed J. C. Cloning and functional analysis of BAG-1: a novel bcl-2-binding protein with anti-cell death activity. Cell 1995; 80: 279–284
   PubMed Web of Science ®Google Scholar
• Minn A. J., Rudin C. M., Boise L. H., Thompson C. B. Expression of Bcl-x-L can confer a multidrug resistance phenotype. Blood 1995; 86: 1903–1910
   PubMed Web of Science ®Google Scholar
• Haber D. A. Multidrug resistance (MDR1) in leukemia: is it time to test?. Blood 1992; 79: 295–298
   PubMed Web of Science ®Google Scholar
• Schlaifer D., Duchayne E., Demur C., Alvinerie P., Muller C., Attal M., Cooper M. R., Payen C., Monsarrat B., Myers C. E., Pris J., Laurent G. Vincristine degradation by serum from leukemic patients: role of myeloperoxidase. Leuk. Lymph. 1995; 18: 179–184
   PubMed Web of Science ®Google Scholar
• Dole M. G., Jasty R., Cooper M. J., Thompson C. B., Nunez G., Castle V. P. Bcl-x-L is expressed in neuroblastoma cells and modulates chemotherapy-induced apoptosis. Cancer Res. 1995; 55: 2576–2582
   PubMed Web of Science ®Google Scholar
• Sumantran V. N., Ealovega M. W., Nunez G., Clarke M. F., Wicha M. S. Overexpression of Bcl-x-S sensitizes MCF-7 cells to chemotherapy-induced apoptosis. Cancer Res. 1995; 55: 2507–2510
   PubMed Web of Science ®Google Scholar